Previous Article | Next Article ![]()
Mol Cell Biol, July 1998, p. 4097-4108, Vol. 18, No. 7
Howard Hughes Medical
Institute2 and
Department of Cell
Biology,1 School of Medicine, Vanderbilt
University, Nashville, Tennessee 37232;
Department of Pathology
and Program in Molecular and Genetic Medicine, School of Medicine,
Stanford University, Stanford, California
943053; and
Department of
Experimental Oncology, St. Jude Children's Research Hospital,
Memphis, Tennessee 381054
Received 16 January 1998/Returned for modification 10 March
1998/Accepted 10 April 1998
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Myb-Related Schizosaccharomyces pombe
cdc5p Is Structurally and Functionally Conserved in
Eukaryotes
SUMMARY
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
ACKNOWLEDGMENTS
REFERENCES
SUMMARY
|
|
|---|
Schizosaccharomyces pombe cdc5p is a Myb-related protein that is essential for G2/M progression. To explore the structural and functional conservation of Cdc5 throughout evolution, we isolated Cdc5-related genes and cDNAs from Saccharomyces cerevisiae, Caenorhabditis elegans, Drosophila melanogaster, and Homo sapiens. Supporting the notion that these Cdc5 gene family members are functionally homologous to S. pombe cdc5+, human and fly Cdc5 cDNAs are capable of complementing the temperature-sensitive lethality of the S. pombe cdc5-120 mutant. Furthermore, S. cerevisiae CEF1 (S. cerevisiae homolog of cdc5+), like S. pombe cdc5+, is essential during G2/M. The location of the cdc5-120 mutation, as well as mutational analyses of Cef1p, indicate that the Myb repeats of cdc5p and Cef1p are important for their function in vivo. However, we found that unlike in c-Myb, single residue substitutions of glycines for hydrophobic residues within the Myb repeats of Cef1p, which are essential for maintaining structure of the Myb domain, did not impair Cef1p function in vivo. Rather, multiple W-to-G substitutions were required to inactivate Cef1p, and many of the substitution mutants were found to confer temperature sensitivity. Although it is possible that Cef1p acts as a transcriptional activator, we have demonstrated that Cef1p is not involved in transcriptional activation of a class of G2/M-regulated genes typified by SWI5. Collectively, these results suggest that Cdc5 family members participate in a novel pathway to regulate G2/M progression.
INTRODUCTION
|
|
|---|
The entrance of eukaryotic cells into mitosis from G2 is a highly regulated event which involves a complex series of interactions among an evolutionarily conserved set of kinases and phosphatases (reviewed in references 41 and 57). Genetic studies with the fission yeast Schizosaccharomyces pombe have identified molecules that participate in the regulation of the G2/M transition through phosphorylation (34, 44-46), including cdc2+, cdc13+, cdc25+, wee1+, and mik1+. cdc2+ encodes the single essential cyclin-dependent kinase (CDK) required to drive fission yeast cells through the cell cycle. During G2, cdc2p is associated with the mitotic B-type cyclin encoded by cdc13+. The activity of cdc2p/cdc13p complexes is inhibited by phosphorylation of cdc2p at tyrosine 15, an event which is catalyzed by the wee1p and mik1p protein tyrosine kinases. As fission yeast cells achieve a critical size required for entry into mitosis, the cdc25p protein tyrosine phosphatase activates cdc2p/cdc13p complexes by catalyzing the dephosphorylation of tyrosine 15.
In addition to genes which regulate cdc2p function directly, two other S. pombe genes, cdc5+ and cdc28+, are known to be required during G2 for entry into mitosis. cdc28+ encodes a DEAH-box protein homologous to the Saccharomyces cerevisiae splicing factors Prp2p, Prp16p, and Prp22p, suggesting that RNA processing is in some way required to promote the G2/M transition (33). The cdc5+ gene product contains a putative DNA-binding domain (DBD) that is most similar to those contained within Myb-related proteins and is the only putative transcription factor cloned in S. pombe that performs an essential role during G2/M progression (49).
Recently identified Arabidopsis thaliana, Homo sapiens, and Xenopus laevis cDNAs encode proteins closely related to S. pombe cdc5p (4, 23, 58). Of these, the A. thaliana cDNA, AtCDC5, was found to be a functional homolog of cdc5+ since it was capable of complementing the temperature-sensitive growth defect of the fission yeast cdc5-120 mutant (23). A partial X. laevis Cdc5 cDNA clone was isolated in a screen designed to identify mitotic phosphoproteins that can be phosphorylated in vitro by cyclin B-Cdc2 (58). In addition, Bernstein and Coughlin (4) have reported that the human Cdc5 protein, PCDC5RP (pombe Cdc5-related protein), translocates from the cytoplasm to the nucleus of cultured mammalian cells stimulated with serum, implicating the human protein as a potential effector in a mitogen-activated signaling pathway.
To explore further the structural and functional conservation of cdc5p, we have isolated cDNAs and genes from S. cerevisiae, Caenorhabditis elegans, Drosophila melanogaster, and H. sapiens that encode homologs of S. pombe cdc5p and report here an analysis of these genes. Supporting a role for this subfamily of Myb-related proteins in G2/M cell cycle progression, budding yeast cells lacking CEF1 (S. cerevisiae homolog of cdc5+) arrest growth during G2/M. Furthermore, we demonstrate that human and fly Cdc5 proteins are functionally homologous to S. pombe cdc5p because they are able to complement the temperature-sensitive lethality of the S. pombe cdc5-120 mutant.
Aside from the sequence similarity of Cdc5-related proteins to the transcriptional activator c-Myb, two lines of evidence have implicated Cdc5 in DNA binding. First, the Myb repeats of S. pombe cdc5p bind DNA-cellulose (49). Second, the Myb repeats of AtCDC5 were found to be capable of preferentially binding to the DNA sequence CTCAGCG (23). In this report, we demonstrate by mutational analysis of the Myb repeats of Cef1p and localization of the cdc5-120 mutation to the Myb repeat R1 of cdc5p that the Myb repeats of these proteins are essential for their function in vivo. In the budding yeast S. cerevisiae, the Mcm1p transcription factor, in concert with an uncloned gene encoding a protein named Sff (SWI5 transcription factor), is required for transcription of at least six genes that normally exhibit a G2/M-specific expression pattern, namely, CLB1, CLB2, CDC5, SWI5, ACE2, and ASE1 (1, 26, 35). On the basis of phenotypic analysis of S. cerevisiae cells genetically depleted of CEF1 activity and the ability of these cells to transcribe gene targets of Mcm1p/Sff, we conclude that CEF1 does not encode Sff. Our work demonstrates that fission yeast cdc5p is a member of a highly conserved subfamily of Myb-related proteins that plays a key role in cell cycle progression at the G2/M boundary.
MATERIALS AND METHODS
|
|
|---|
Strains, growth media, and genetic methods. The S. cerevisiae and S. pombe strains used in this study are listed in Table 1. Media used to grow S. pombe and general genetic manipulations of S. pombe were described previously (39). S. pombe transformations were performed by electroporation (50). Repression of transcription from the nmt1+ promoter (37) was achieved by addition of thiamine to a concentration of 2 µM.
|
Isolation and molecular cloning of CEF1 and the Cdc5Ce, Cdc5Dm, and Cdc5Hs. A 2,555-bp fragment encompassing the CEF1 gene was amplified from genomic DNA by using primers cef1.P5 (5'-CCCGGATCCGGCTTCTTATCTGTGGTC-3') and cef1.P6 (5'-CCCCTGCAGCCGGATGGTACTTCTTAG-3') (introduced restriction enzyme sites are italicized). cef1.P5 introduces a BamHI site onto the 5' end of the CEF1 gene, and cef1.P6 introduces a PstI site onto the 3' end of the CEF1 gene. The PCR product was cleaved with BamHI and PstI and ligated into pRS415 (9), which had been cut with BamHI and PstI to produce the plasmid pCEF1. The CEF1 open reading frame (ORF) was sequenced to ensure the absence of PCR-induced mutations. A URA3-CEN plasmid (pRS416) containing the CEF1 gene, which was used in all plasmid shuffle assays, was constructed by inserting the BamHI/HindIII CEF1 fragment from pCEF1 into pRS416, which had been cleaved with these enzymes. The 1,770-bp CEF1 ORF was amplified from S. cerevisiae genomic DNA by using primers SC5531 (5'-GCCGATATCTACTAGCATTTCAAGATGCCC-3') SC5351 (5'-GAAGATATCCTATACTAATGCTATATGGAA-3'). Both primers were designed to add EcoRV restriction sites to the ends of the coding region during amplification. The amplified fragment was cut with EcoRV and cloned into the EcoRV site of pSKREG351 to produce pSKREG351CEF1. pSKREG351 is pBS(SK+) (Stratagene, LaJolla, Calif.) containing 585 bp of nucleotide sequence immediately upstream of the S. pombe cdc5+ ATG. The cdc5+ promoter sequence was amplified by using primers 5REG351 (5'-GAAGATATCAACCCTGAC-3') and T7 and cloned into pBS(SK+) which had been linearized with EcoRV and treated with dTTP and Taq polymerase. The EcoRV fragment from pSKREG351CEF1 was subcloned into the SmaI site of the 2 µm LEU2-based shuttle vector pRS425GAL1 (42) to produce pGAL1-CEF1. pCEF1 and pGAL1-CEF1 both produce functional Cef1p since they are capable of restoring growth to a strain lacking the CEF1 gene.
A C. elegans
cDNA clone, YK82fl, whose partial
translation product had high sequence identity to a portion of the Myb
repeats of cdc5p, was obtained from Yuji Kohara of the Gene Library Lab at the National Institute of Genetics (Mishima, Japan). The insert of
this clone was subcloned and sequenced in its entirety on both strands.
The fly homolog of the cdc5+ gene was isolated
by sequential nested PCR with D. melanogaster genomic DNA by
using the following degenerate primers: Aout, 5'-A(G/A)A
T(T/C/A)(T/C) TNA A(G/A)G CNG CNG T-3'; Ain, 5'-AA(G/A)
TA(T/C) GGN AA(G/A) AA(T/C) CA(A/G) TGG-3'; Bout, 5'-NGC
(T/C)TT NCC (T/C)TG NGT (A/G)TT-3'; Bin, 5'-(T/C)TC (A/G)TC
(T/C)TC (A/G)TC CAT (G/A)TC (A/T/G)AT-3'. The corresponding amino acid
sequences of these primers are as follows: Aout, EILKAAV;
Ain, KYGNQW; Bout, NTQGKKA; Bin,
IDMDEDE. Following the second round of PCR, a band of 431 bp was
obtained and subcloned into the TA vector (InVitrogen, Carlsbad,
Calif.). Five clones were sequenced and found to be identical. This
431-bp fragment was then used to screen an adult Drosophila
Canton S strain genomic
library (Clontech, Palo Alto, Calif.; a
gift from M. Fuller). A 4.5-kb XhoI fragment encompassing
the entire Cdc5Dm gene locus was subcloned from a positive
clone
and sequenced in its entirety. The amino acid sequence was inferred
from the genomic sequence based on homology to other Cdc5 family
members.
To isolate Cdc5Hs cDNAs, an I.M.A.G.E. clone (Consortium Clone ID
74654) that contains a 185-bp human expressed sequence tag (EST) whose
translation product has high sequence identity to a portion of the Myb
repeats of cdc5p was obtained from the American Type Culture Collection
(Rockville, Md.) and used to screen a cDNA library constructed from a
human microvascular endothelial cell line (a gift from T. O. Daniel). Eight positive clones were obtained after screening
approximately 5 × 105 phage clones. The longest
clone, pSKCdc5Hs.10, was cleaved with convenient restriction enzymes to
generate a bank of truncated clones to facilitate sequencing. The
sequence of the Cdc5Hs gene was determined on both strands by using
either custom synthesized oligonucleotides (Operon, Alameda, Calif.),
M13 reverse primer, or T7 primers.
Chromosomal mapping of Cdc5Hs. To determine the chromosomal location of the Cdc5Hs gene, three PAC clones (11107, 11108, and 11109; Genome Systems, St. Louis, Mo.) were isolated by using full-length Cdc5Hs cDNA as a probe. PAC clone 11108 was labeled with digoxigenin-11-dUTP (Boehringer Mannheim, Indianapolis, Ind.) by nick translation. The labeled probe was combined with sheared human DNA and hybridized to normal metaphase chromosomes derived from phytohemagglutinin-stimulated peripheral blood lymphocytes in a solution containing 50% formamide, 10% dextran sulfate, and 2× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate). Specific hybridization signals were detected by incubating the hybridized slides in fluorescein-conjugated sheep antibodies to digoxigenin (Boehringer Mannheim). The chromosomes were then counterstained with 4',6-diamidino-2-phenylindole (DAPI) and analyzed. Definitive chromosomal assignment to chromosome 6 was confirmed by cohybridization of clone 11108 with a biotinylated chromosome 6 centromere-specific probe (D6Z1; Oncor Inc., Gaithersburg, Md.). Specific probe signals were detected by incubating the hybridized slides in fluorescein-conjugated sheep antibodies to digoxigenin and Texas red avidin (Vector Laboratories, Burlington, Calif.) followed by counterstaining with DAPI. Band assignment was made by conducting fractional length measurements of 10 specifically hybridized chromosomes 6.
Disruption of CEF1 and construction of KGY1120.
Deletion of the CEF1 coding sequence was performed by
replacing nearly the entire ORF with a DNA fragment containing the
HIS3 gene. The cef1-
1::HIS3 null
allele was generated by PCR as described by Baudin et al.
(3; see also reference 53), using
the primers 5'-GCATTTCAAGATGCCCCCCGTACCAATATACGTGAGCAGATTGTACTGAG-3'
and
5'-CATGGCTTGAAGACGCTTTCTTCTACGACCCTCAAGCGCTCCTTACGCATCTG-3' and pRS313 (55) as a template to amplify the
HIS3 gene. The underlined portions of each primer correspond
to the HIS3 flanking sequence. The resulting PCR product
contains the complete HIS3 gene flanked by 35 bp of
CEF1 5' sequence corresponding to nucleotides
10 to +25
and 35 bp of CEF1 3' sequence corresponding to nucleotides +1714 to +1748. When substituted at the CEF1 locus, this DNA
fragment deletes the entire CEF1 gene except for the initial
8 codons and final 18 codons. The diploid strain YPH274 was transformed
with this DNA fragment, and two independent transformants (KGY856 and KGY857) that contained a cef1-
1::HIS3 allele
substituted correctly at one of the two CEF1 loci were
identified by Southern analysis. These strains were sporulated, and
tetrads were dissected and analyzed.
Leu+.
Cytological methods and flow cytometry. To visualize nuclei, cells were fixed with 70% ethanol overnight at 4°C, washed twice with phosphate-buffered saline, and resuspended in 1 µg of DAPI per ml. For immunostaining of tubulin, cells were processed as outlined by Pringle et al. (51) and stained with TAT-1 monoclonal antibody (65) followed by a Texas red-conjugated goat-anti mouse immunoglobulin G secondary antibody. Cells were viewed with a Zeiss Axioskop20 with the appropriate set of filters, and images were captured with a Zeiss ZVS-47DEC image-capturing system. Yeast cells were processed for flow cytometric analysis as described previously (49).
Mutagenesis of Cef1p. To generate single amino acid substitutions in Cef1p, pCEF1 was mutagenized by using the Muta-gene in vitro mutagenesis kit (Bio-Rad Laboratories, Hercules, Calif.) or the Chameleon double-stranded mutagenesis kit (Stratagene). All mutations were confirmed by the presence of introduced restriction enzyme sites and sequencing. Double, triple, and quadruple mutants were constructed by using a unique BglII site that cuts between the codon for the third tryptophan in Myb repeat R1 and that for the second tryptophan in Myb repeat R2.
pGAL1-CEF12R contains the sequence for the first two Myb repeats of Cef1p inserted downstream of the GAL1 promoter in pRS425GAL1 (42). The coding sequence for R1R2 was amplified by using pCEF1 as the template and the primers Cef12R.5' (5'-AAAGGATCCATGCCCCCCGTACCAATA-3') and Cef12R.3' (5'-TTTCTGCAGTTTCTAACTAGTTTGAGTTTCAGCGTTAGG-3'), which insert BamHI and PstI sites onto the 5' and 3' ends of the PCR product, respectively. pGAL1-CEF1CT contains the sequence for the C-terminal portion of Cef1p including the Myb-like repeat 3 (MLR3) sequence in pRS425GAL1. The coding sequence for this region of Cef1p was also amplified by using pCEF1 as the template and the primers Cef1CT.5' (5'-AAAGGATCCATGGCTAGACCAGATAATGG-3') and Cef1CT.3' (5'-TTTCTGCAGTTTCTAACTAGTTATGGAAGAAGAAGAATTTAGCATGGCTTG-3'), which insert BamHI and PstI sites onto the 5' and 3' ends of the PCR product, respectively. Both of the amplification products were cloned into the BamHI and PstI sites of pRS425GAL1 and sequenced to ensure the absence of PCR-induced mutations. The pGAL1-CEF1dR1 and pGAL1-CEF1dR2 constructs were generated as follows. The coding sequence for Cef1p lacking R1 was generated by PCR using the primers CEF1dR1 (5'-AAAGGATCCATGTTGAATTTTACAGAGTTC-3') and Cef1CT.3'. The CEF1dR1 primer inserts a BamHI site at the 5' end of the PCR product. The amplification product was cloned into the BamHI and PstI sites of pRS425GAL1 and sequenced to ensure the absence of PCR-induced mutations. pGAL1-CEF1dR2 was constructed by inserting HindIII sites at the end of the coding sequence for R1 and at the beginning of the coding sequence for MLR3 by using pGAL1-CEF1 as the template. The internal HindIII fragment coding for R2 was then released from the vector, and the vector was religated to itself. The mutagenesis results in sequence coding for the insertion of a single amino acid, leucine, between R1 and MLR3. The oligonucleotides used for this mutagenesis are as follows: EndR1.HIII, 5'-TGGAATGAATATTTAAATCCAAAGCTTAATTTTACAGAGTTCTCGAAGG-3'; BeginMLR3.HIII, 5'-GATATTAATCCTAACGCTGAAAAGCTTATGGCTAGACCAGATAATGGTG-3'; SWPstBam, 5'-CAAGCCATGCTAAATTCTTCTTCTTAAATAACTAGTTAGTATAGGATGGGGGATCCGAATTCGATATCAAGCTTATCG-3'.Preparation of total RNA and Northern blot analysis. S. pombe wild-type (strain 972) and temperature-sensitive strains were grown to mid-log phase at 25°C in yeast extract medium. Aliquots of the cultures were collected while the remaining portions were shifted to 37°C. Cells at 37°C were collected following a 5-h incubation. S. cerevisiae KGY1120 cells were grown to mid-log phase in synthetic medium containing the appropriate supplements and 2% raffinose-2% galactose (SRG medium) as the carbon sources. A portion of the culture was collected for processing, while the remainder of the culture was harvested and resuspended in synthetic medium containing glucose (SD medium) and the appropriate supplements. Cells were collected for processing at 8, 10, 12, 14, and 16 h following the SRG-to-SD medium shift. Total RNA was prepared from S. cerevisiae and S. pombe cells by glass bead disruption as described by Moreno et al. (39) or by RNeasy columns (Qiagen, Chatsworth, Calif.). Twenty micrograms of total RNA was electrophoresed on 1% formaldehyde agarose gels, blotted onto Gene Screen Plus membranes (DuPont-NEN, Boston, Mass.), and fixed by incubation at 80°C under vacuum for 2 h. Hybridization was performed as described by Church and Gilbert (10). Templates for probes were prepared from genomic DNA by PCR or by releasing appropriate fragments from plasmids by restriction enzyme digestion. Probes for hybridization were prepared by using the Rediprime random primer labeling system (Amersham, Arlington Heights, Ill.).
RESULTS
|
|
|---|
S. pombe cdc5p is conserved throughout evolution: isolation of and structural analysis of Cdc5 gene homologs. We previously reported that the S. pombe cdc5+ gene encodes a protein that has significant sequence similarity to the c-Myb family of proteins (49). More recently, genome sequencing efforts have revealed that gene products much more closely related to cdc5p than c-Myb family members exist in diverse eukaryotic organisms, including S. cerevisiae, C. elegans, and H. sapiens. Additionally, Hirayama and Shinozaki (23), Bernstein and Coughlin (4), and Stukenberg et al. (58) have reported the identification of cDNAs from A. thaliana, H. sapiens, and X. laevis, respectively, whose predicted proteins are closely related to cdc5p. To determine if the cell cycle function of S. pombe cdc5+ also has been conserved throughout evolution, we isolated presumptive homologs of cdc5+ from S. cerevisiae, C. elegans, D. melanogaster, and H. sapiens.
Comparison of the complete amino acid sequence of cdc5p with those of all the translation products of the ORFs present within the S. cerevisiae genome identified a single translation product which displays significant similarity to cdc5p. For this reason, we have designated the corresponding previously uncharacterized ORF (YMR213w) CEF1 for S. cerevisiae homolog of cdc5+. The 1,770-bp CEF1 ORF is located on chromosome XIII and encodes a protein of 590 amino acids (aa) with a predicted molecular size of 68 kDa (Fig. 1A).
|
clone YK82fl) whose translation
product has high sequence identity to a portion of the Myb repeats of
cdc5p. The complete primary structure of the presumptive C. elegans homolog was revealed by sequence analysis of the
clone
and by sequencing of cosmid D1081 by the C. elegans genome
sequencing project. The Cdc5Ce gene encodes a protein of 755 aa with a
predicted molecular size of 86 kDa (Fig. 1A).
A fragment of the D. melanogaster cdc5+ homolog,
the Cdc5Dm gene, was identified by sequential nested PCR using primers
designed to anneal to highly conserved portions of Cdc5 family members (see Materials and Methods). This fragment was then used as a probe to
isolate a genomic clone containing the entire Cdc5Dm gene coding
sequence. cDNA clones were then isolated by reverse transcription-PCR
and sequenced. The Cdc5Dm protein is 814 aa in length and has a
predicted molecular size of 93 kDa (Fig. 1A).
By using a 185-bp human EST (Consortium CloneID 74654), a full-length
cDNA clone encoding the putative human homolog of cdc5p, Cdc5Hs, was
found to contain a 2,406-bp ORF capable of coding for an 802-aa protein
with a predicted molecular size of 93 kDa (Fig. 1A). The predicted
amino acid sequence of the Cdc5Hs gene is identical to that of PCDC5RP
reported by Bernstein and Coughlin (4). In agreement with
the results obtained by Bernstein and Coughlin (4), we have
detected a Cdc5Hs gene transcript in a variety of human tissues and
cell lines of ~3.4 kb, which is consistent with the size of the
isolated full-length cDNA clones (data not shown). To determine the
chromosomal location of the Cdc5Hs gene, a human genomic PAC clone
spanning the Cdc5Hs gene locus was isolated and used for fluorescence
in situ hybridization (see Materials and Methods). This analysis
demonstrated that the Cdc5Hs gene is localized to chromosome 6p21 (data
not shown).
Comparison of the amino acid sequences of Cdc5 family members has
revealed that they are structurally similar to each other throughout
their entire lengths (see bottom of Fig. 1A for percent identities
among the various Cdc5 family members). The first ~100 aa of Cdc5
relatives, which encompass two complete Myb repeats, resemble classical
Myb repeats in that each repeat contains three tryptophan residues that
are separated by an interval of 18 or 19 aa (reviewed in reference
32). The single exception to this is that the third
position in the second repeat (R2) of Cdc5 family members is occupied
by a tyrosine residue (Fig. 1A). The presence of hydrophobic residues
at these positions is essential for the DNA binding and transcriptional
activation properties of c-Myb (27, 54). Mutational and
modeling studies of c-Myb predicted that the Myb repeat forms a
structure related to a helix-turn-helix motif in which each tryptophan
residue forms the hydrophobic backbone of a helix (15, 17).
This prediction has been confirmed through nuclear magnetic resonance
solution spectroscopy, and these studies have further demonstrated that
the minimal Myb DBD (R2R3) contacts DNA through the third helix of each
imperfect repeat (47, 48). Mutational studies and analysis
of the oncogenic avian myeloblastosis virus product, v-Myb, have
demonstrated that alteration of a number of other residues within the
DBD of c-Myb results in loss of DNA binding and transcriptional
activation capabilities (7, 15, 17, 19, 22, 24, 43). A
number of these residues are conserved between c-Myb and Cdc5 family
members (49) (Fig. 1A).
Cdc5 family members contain a ~60-aa Myb-like repeat located
immediately adjacent to the second repeat (Fig. 1A and B). At the amino
acid level, the third Cdc5 Myb-like repeat (labeled MLR3 in Fig. 1A) is
significantly divergent from that found in c-Myb, although certain
residues are conserved among all c-Myb and Cdc5 family members analyzed
(Fig. 1B). Interestingly, MLR3 lacks the hydrophobic residues which
form the helical backbones in a Myb repeat. As observed by Hirayama and
Shinozaki (23) and Bernstein and Coughlin (4)
regarding AtCDC5, human Cdc5, and S. pombe Cdc5p, the
central third of Cdc5 family members harbors a significant number of
potential phosphorylation sites for proline-directed kinases (S/TPXK/R
or S/TPK/R), which suggests that Cdc5 activity may be regulated by
phosphorylation in vivo. Consistent with this notion is the finding
that X. laevis Cdc5 is phosphorylated by mitotic egg
extracts and cyclin B-Cdc2 (58). Sequence similarity among
Cdc5 family members decreases in the C-terminal third of the sequence,
where significant identity is observed primarily among the C. elegans, D. melanogaster, A. thaliana, and
H. sapiens proteins.
The temperature-sensitive growth defect of the S. pombe cdc5-120 mutant is complemented by both human and fly Cdc5 cDNAs. To determine if CEF1 and the Cdc5Ce, Cdc5Dm, and Cdc5Hs cDNAs were capable of rescuing the temperature-sensitive lethality of the S. pombe cdc5-120 mutant (46, 49), we introduced these cDNAs into cdc5-120 cells under control of the thiamine-repressible nmt1+ promoter (37). Full-length cDNAs for CEF1 and the Cdc5Ce and Cdc5Hs cDNAs were incapable of rescuing growth of cdc5-120 cells at 36°C in both the presence and absence of thiamine (Fig. 2). In contrast, the full-length Cdc5Dm cDNA was capable of rescuing growth of cdc5-120 cells when induced (in the absence of thiamine) but not when repressed (in the presence of thiamine) (Fig. 2). Microscopic examination of cdc5-120 cells overexpressing CEF1 and the Cdc5Hs cDNA revealed that many of them were elongated at 25°C (data not shown). Overexpression of full-length CEF1 and the Cdc5Hs cDNA had the same phenotypic consequence in wild-type cells (data not shown).
|
EcoRI) or 196 aa (
Acc651) in Cdc5Hs
were able to complement the temperature-sensitive growth defect of
cdc5-120 cells in the absence of thiamine but not in the
presence of thiamine. Cdc5Dm truncated by 293 aa at the C terminus was
also capable of complementing the temperature-sensitive growth defect
of cdc5-120 in the absence of thiamine but not in the
presence of thiamine. A CEF1 ORF coding for a protein
truncated by 150 aa at the C terminus, which did not cause elongation
of S. pombe cells in the absence of thiamine (data not
shown), was unable to restore growth of cdc5-120 cells at
36°C (Fig. 2). Cdc5Ce truncated by 337 aa was also unable to rescue
growth of cdc5-120 cells at 36°C (Fig. 2). The inability
of Cef1p and Cdc5Ce to restore growth of cdc5-120 cells at
36°C could be due to inappropriate levels of protein expression
and/or insufficient structural similarity to S. pombe cdc5p.
The ability of the Cdc5Dm cDNA and truncated versions of the Cdc5Hs
cDNA to rescue growth of cdc5-120 cells at 36°C, however,
clearly establishes these genes as functional homologs of S. pombe cdc5+.
CEF1 is essential during G2/M.
To help
determine the role of CEF1 in budding yeast, a complete
deletion of one genomic copy of the gene was created in a diploid
strain (see Materials and Methods). Precise replacement of one of the
copies of CEF1 by a CEF1::HIS3
disruption fragment was confirmed by Southern blot analysis and PCR
(data not shown). Two independent
cef1-
1::HIS3/CEF1 heterozygotes were
sporulated, and tetrads were dissected. In each case, only two
His
colonies grew, demonstrating that CEF1 is
essential for viability in S. cerevisiae. His+
haploid colonies could be recovered following sporulation of the
cef1-
1::HIS3/CEF1 diploid heterozygote if a
plasmid carrying the CEF1 gene was introduced into the
strain prior to sporulation. Neither the human Cdc5 cDNA nor S. pombe cdc5+ was found to be capable of complementing
the lethality of S. cerevisiae cef1-
1::HIS3
cells. Microscopic observation of cef1-
1::HIS3 cells in dissected tetrads revealed that they underwent one or two
rounds of cell division and then experienced growth arrest as large
budded cells (data not shown).
|
|
Mutational analysis of Cef1p.
The importance of the two Myb
repeats and MLR3 of Cdc5 family members to their function is predicted
by the high degree of sequence identity among them (Fig. 1A). As
expected, Myb repeats R1 and R2 of Cef1p are essential for its function
in vivo; when expressed under control of the GAL1 promoter,
a truncated version of Cef1p lacking the R1 and R2 Myb repeats
(pGAL1-CEF1CT) is incapable of rescuing the growth of the
cef1-
1::HIS3 mutant (Fig.
4). Furthermore, the mutation responsible
for causing the temperature sensitivity of the S. pombe
cdc5-120 mutant was sequenced and found to be present in the first
Myb repeat (R1). In cdc5-120p, the second tryptophan of R1 (W29) is
converted to an arginine residue as a result of a T:A to C:G mutation
at the corresponding codon (TGG to CGG). Although these results
underscore the importance of the Cef1p and cdc5p Myb repeats, a
construct containing only R1 and R2 of Cef1p under control of the
GAL1 promoter (pGAL1-CEF12R) is incapable of
rescuing the growth of the cef1-
1::HIS3 mutant, indicating that other regions of Cef1p are essential for function as
well (Fig. 4).
|
6 relative to the
third tryptophan. Substitution of this lysine with an asparagine in
c-Myb results in loss of DNA binding (15), and mutational
analysis of this residue in Petunia MYB.Ph3 indicates that
this residue plays a role in determining sequence-specific binding of
MYB.Ph3 to DNA (56). Finally, Cdc5 family members contain a
cysteine residue at position
4 relative to the third tryptophan in
both R1 and R2 (Fig. 1A). Cef1p is exceptional in this case because it
contains a serine in place of a cysteine in R1. In c-Myb, replacement
of a cysteine residue in a homologous position in R2 with a serine
results in a dramatic reduction of DNA binding in vitro (20,
43), raising the possibility that modulation of the oxidation
state of this cysteine may be a way of regulating the DNA-binding
activity of c-Myb.
To analyze the in vivo consequences of altering these key residues
within the Cef1p Myb repeats which are conserved among Cdc5 family
members and c-Myb, we generated mutations within the Myb repeats of
Cef1p by site-directed mutagenesis (see Materials and Methods) and
tested the ability of these mutants to restore growth of cells which
lack CEF1. All of the single mutations that were constructed
result in nonconservative amino acid substitutions and are located in
positions that are important for maintaining structure of the second
(W33R, W33G, W84G) and third (R46N, W52A, W52G, C98S, Y102A, Y102G)
helices in the corresponding Myb repeats (Fig. 4) (15, 17, 27,
43). Various double, triple, and quadruple mutations which are
predicted to disrupt conformation of the second and third helices in
both of the canonical Myb repeats of Cef1p were also constructed.
As shown in Fig. 4, all of the single mutants were found to be fully
capable of rescuing the growth of the
cef1-
1::HIS3 mutant, demonstrating that the
substitutions in these mutants do not abolish Cef1p function in vivo.
Interestingly, reconstruction of the cdc5-120 mutation in
CEF1 (cef1-120) does not produce a
temperature-sensitive phenotype in S. cerevisiae. All of the
double-mutant combinations were also able to rescue growth of cells
lacking CEF1. Notably, however, the W33G W84G and W52G W84G
mutants were not able to rescue the growth of
cef1-
1::HIS3 cells as well as the wild-type CEF1 protein at 30°C. Furthermore,
cef1-
1::HIS3 cells harboring these double
mutants were temperature sensitive (Fig. 4) and underwent growth arrest
following two to four cell divisions at 36°C as large-budded cells
(data not shown). Of the four triple mutants that were analyzed, only
two, W33G W52G Y102G and W52G W84G Y102G, rescued the growth of the
cef1-
1::HIS3 mutant, and the latter conferred
only poor growth to cells lacking the CEF1 gene. Similar to
the W33G W84G and W52G W84G mutants, these triple mutants were incapable of restoring growth to cells lacking CEF1 at
36°C. The W33G W52G W84G Y102G quadruple mutant was unable to rescue
growth of the cef1-
1::HIS3 mutant.
The ability of the W33G W52G and W84G Y102G double mutants, which are
predicted to disrupt the second and third helices in R1 and R2,
respectively, to rescue growth of cells lacking CEF1 raised
the issue of whether R1 and R2 are functionally redundant in vivo. We
tested this directly by individually removing R1
(pGAL1-CEF1dR1) and R2 (pGAL1-CEF1dR2) from the
pGAL1-CEF1 construct. Neither of the deletion mutants was
capable of rescuing the growth of the
cef1-
1::HIS3 mutant, demonstrating that the
Cef1p Myb repeats are not functionally redundant. Collectively, these
results indicate that the Myb repeats of Cef1p perform an essential
function and that structural alteration of the Myb repeats is capable
of eliciting a temperature-sensitive phenotype or abolishing function
of Cef1p in vivo.
CEF1 and S. pombe cdc5+ are not required for expression of genes which are known to be transcriptionally up-regulated during G2/M. The G2/M and G2 growth arrest phenotypes of S. cerevisiae cells lacking CEF1 activity and S. pombe cdc5-120, respectively, and the similarity of Cdc5 family members to c-Myb prompted us to examine a potential involvement of these proteins in the transcriptional activation of genes known to be up-regulated during G2/M. In S. cerevisiae, at least six genes show a G2/M-specific pattern of transcription: SWI5, CLB1, CLB2, ACE2, CDC5, and ASE1 (1, 26, 35). The first five of these genes, and very likely the sixth as well, require the activity of the MADS-box transcription factor encoded by MCM1 and an uncloned protein termed Sff (1, 26, 35). To test whether Cef1p was required for transcriptional activation of these genes, total RNA was prepared from cells depleted of CEF1 activity and subjected to Northern blot analysis using portions of CLB1 and SWI5 ORFs as probes. As shown in Fig. 5A, CLB1 and SWI5 transcripts persist in cells depleted of CEF1 activity, suggesting that CEF1 is not required for expression of these genes.
|
DISCUSSION
|
|
|---|
In this study, we have reported the identification and characterization of cDNAs and genes from S. cerevisiae, C. elegans, D. melanogaster, and H. sapiens that encode proteins closely related to S. pombe cdc5p. Bernstein and Coughlin (4) have independently reported the isolation of human Cdc5 (PCDC5RP). In addition, Hirayama and Shinozaki (23) have reported the isolation and characterization of AtCDC5, a gene which encodes the A. thaliana homolog of fission yeast cdc5p. Stukenberg et al. (58) have identified an X. laevis relative, and genome sequencing efforts have revealed the existence of a Cdc5-related protein in mice (for an example, see the EST under GenBank accession no. AA269568). When subjected to phylogenetic analysis, all of the analyzed Cdc5 family members display significantly greater similarity to S. pombe cdc5p than to any other Myb-related protein (Fig. 1C). cdc5p is thus a member of a family of Myb-related proteins that has been highly conserved throughout the eukaryotic lineage. In S. cerevisiae, only one gene, CEF1, encodes a protein that bears any significant similarity to fission yeast cdc5p. This also appears to be the case in complex metazoan systems, since all of about 20 Cdc5Hs-related human sequences in dbEST appear to represent overlapping segments of a single gene which we have mapped to chromosome 6p21. Since mammalian Cdc5 activity is likely encoded by a single genetic locus, it is possible that inappropriate modulation of Cdc5 activity may be associated with the onset or progression of tumorigenesis. Although no obvious previously described cancer or disease genes have been mapped to this locus, knowledge of its chromosomal location provides an opportunity to investigate such a possibility directly.
Several lines of evidence suggest that the cell cycle function of
S. pombe cdc5+ has also been conserved
throughout the eukaryotic lineage. Like S. pombe
cdc5+, S. cerevisiae CEF1 is essential for
viability. Haploid cells lacking a functional CEF1 gene
undergo growth arrest with a 2N DNA content and short intranuclear
spindles, indicating that they are arrested during G2/M.
Interestingly, a noticeable population of cells lacking CEF1
activity display abnormal nuclear morphologies, indicating that Cef1p
may be important for maintenance of nuclear integrity prior to or
during the process of nuclear division. Similarly, in S. pombe, approximately 30% of fission yeast cells lacking the
cdc5+ gene also display aberrant nuclear
morphologies (49). Despite the sequence identity possessed
by Cef1p and cdc5p, CEF1 is unable to complement the
temperature-sensitive growth defect of S. pombe cdc5-120 at
its restrictive temperature of 36°C. Similar to AtCDC5 (23), H. sapiens and S. cerevisiae
Cdc5 cDNAs are unable to rescue growth of S. pombe cells
harboring a deletion of cdc5+. Human and fission
yeast Cdc5 proteins were also observed to be incapable of rescuing the
lethality of S. cerevisiae cef1
cells. The inability of
various Cdc5 family members to rescue growth of cef1
or
cdc5
cells is not surprising given that the C termini of
Cdc5 family members are less well conserved than the putative DBDs and
that the C termini of S. pombe cdc5p and S. cerevisiae Cef1p have indispensable functions (49, 49a) (Fig. 4). Full-length Cdc5Dm and partially truncated human Cdc5, however, were capable of rescuing growth of cdc5-120 cells
at 36°C, thus demonstrating that Cdc5Hs and Cdc5Dm are functional homologs of fission yeast cdc5p. The inability of the Cdc5Ce cDNA and
S. cerevisiae CEF1 to rescue growth of cdc5-120
is most simply explained by a limited degree of sequence identity
possessed by the Myb repeats of S. pombe cdc5p, Cdc5Dm, and
Cdc5Hs (Fig. 1A). Recently, Bernstein and Coughlin (4) have
reported that an epitope-tagged version of human Cdc5 translocates from
the cytoplasm to the nuclei of serum-deprived cultured mammalian cells
upon stimulation with serum. Based on these results, the authors
speculated that Cdc5 may function in a mitogen-activated signaling
pathway during the G0/G1 transition. Although a
definitive role(s) for Cdc5 in the mammalian cell cycle requires
further analysis, our data indicate that an essential, conserved
function of Cdc5 in the eukaryotic cell cycle is at the
G2/M transition.
In S. cerevisiae, the Mcm1p transcription factor, in combination with the uncloned SWI5 factor (Sff), is required during G2/M to activate transcription of at least six genes which are necessary for entry into and completion of mitosis: CLB1, CLB2, ACE2, SWI5, CDC5, and ASE1 (1, 26, 35). Sff is absolutely required for transcription of SWI5 because mutation of the Sff binding site results in the loss of SWI5 upstream activating sequence activity (35). S. cerevisiae cells lacking MCM1 activity undergo growth arrest with replicated DNA and elongated buds (1), a phenotype commonly associated with S. cerevisiae mutants which possess low Clb-associated Cdc28p (Cdk1) kinase activity (31, 52, 59). Cells lacking CEF1 undergo arrest with a round-budded phenotype, which indicates the presence of Clb-associated Cdk1 activity (31). The phenotypic difference between cells lacking MCM1 and CEF1 activities indicates that CEF1 is unlikely to encode Sff. We have confirmed this hypothesis by demonstrating that cells depleted of CEF1 activity are capable of accumulating transcripts of Mcm1p and Sff target genes.
In S. pombe, cdc13p and cdc25p levels oscillate in a cell cycle-dependent manner, with maximal levels observed near the G2/M transition (12, 40). cdc25+ transcript is most abundant near the G2/M transition, indicating that accumulation of cdc25p during G2 is achieved, at least in part, through its transcriptional activation (40). The cdc5-120 mutant is not defective for transcription of these mitotic regulators. We conclude from these results and those obtained from Cef1p-depleted cells that Cdc5 does not regulate the G2/M transition in eukaryotic cells at the level of transcription of these known mitotic regulators.
Although cdc5p and Cef1p do not appear to function through activating transcription of genes known to be up-regulated during G2/M, it is still tempting to assign these proteins a role as DNA-binding proteins for the following reasons: (i) all Cdc5 family members analyzed thus far contain two highly conserved Myb repeats, (ii) the S. pombe cdc5-120 mutation converts the second tryptophan in R1 of cdc5p to an arginine residue, and (iii) the Myb repeats of AtCDC5 have been shown to preferentially bind a specific nucleotide sequence (23). For these reasons, we have tried to identify a preferential DNA-binding sequence for S. pombe cdc5p and S. cerevisiae Cef1p. Specifically, we employed the cyclic amplification and selection of target sequence (CASTing) approach with the binding (23, 62) and washing (16) conditions described previously. The N-terminal 201 amino acids of Cef1p, which contain R1, R2, and MLR3, were fused downstream of glutathione S-transferase (GST), and this fusion protein was used for CASTing. An oligonucleotide library containing a core of 20 random nucleotides was used as a probe. A similar approach was used to identify a target sequence of AtCDC5 (23). While it is clear that the Myb repeats of Cef1p and cdc5p have the ability to bind DNA, we have not been able to select a high-affinity binding sequence for these proteins although under the same conditions a fusion protein between GST and the DBD of AML was able to select the sequence TGT/cGGT, the known high-affinity target sequence of AML (38, 49, 49b). In a separate experiment, a hexahistidine-tagged version of the DBD of Cdc5Dm was used in an electrophoretic mobility shift assay with the AtCDC5 binding sequence as a probe. We reasoned that since the DBDs of these proteins have 80% identity, they may be capable of binding the same sequence. While a modest binding of Cdc5Dm to this probe was observed, the binding was abrogated in the presence of increasing amounts of nonspecific competitor, indicating that this interaction occurs with low affinity (37a). In this regard, it is noteworthy that AtCDC5 binding to the sequence CTCAGCG was also reduced with nonspecific competitor DNA (23). While these data may argue that Cdc5 does not bind a particular DNA sequence with high affinity, we cannot exclude the possibility that additional regions of these proteins are required for sequence-specific DNA binding or that they require additional factors to bind DNA with high affinity.
In this study, we have analyzed the in vivo consequences of altering residues within the Cef1p Myb repeats which are predicted to disturb the conformation of these domains. Of particular relevance to this work, mutational studies of c-Myb have demonstrated that hydrophobic residues forming the backbones of the DBD helices are essential for the DNA-binding activity of c-Myb in vitro and its trans-activation activity in reporter assays (27, 54). Surprisingly, we found that the Cef1p Myb repeats are quite resiliant to similar changes; single, double, or even certain triple mutant combinations in residues which form the hydrophobic backbones of the second or third helices in both R1 and R2 do not abolish Cef1p function in vivo, although many produce a temperature-sensitive growth defect. Although these results are unexpected, it is important to bear in mind that our assay determined the functional effects of altering helical backbone residues in vivo and is therefore not directly comparable to the DNA binding, transcriptional activation, and differentiation assays that have traditionally been used in mutational analyses of c-Myb. To our knowledge, systematic mutational analyses of Myb domains in other proteins, such as those presented here, have yet to be reported. Thus, it is possible that interaction of Cef1p with other proteins in vivo may stabilize the conformation of mutant Myb repeats, thus allowing Cef1p to bind DNA.
An intriguing, equally plausible interpretation is that in vivo, Cef1p
may cooperate with a second DNA-binding protein whose activity
compensates for a diminution of Cef1p DNA-binding activity. Evidence
does exist for Myb-related proteins functioning in heterodimeric complexes. c-Myb itself cooperates with heat shock factor 3 (HSF3) to
activate transcription from the hsp70 promoter (28,
29). In S. cerevisiae and Zea mays, the
Myb-related proteins Bas1p and C1, respectively, are thought to act in
concert with a second DNA-binding protein to activate transcription of
target genes; Bas1p cooperates with the homeobox protein Bas2p, and C1
is thought to dimerize with basic helix-loop-helix proteins such as B,
R, SN, and LC (13, 18, 36, 61). In the cases of C1 and
c-Myb, heterodimerization has been shown to require the Myb domains
(18, 28). The in vivo activity of Cef1p clearly requires
both R1 and R2. Perhaps, as in the case of C1, R1R2 of Cef1p functions as both a protein-protein interaction domain and a DBD. Evidence also
exists for heterodimeric transcription factor complexes that require
only one active DNA-binding subunit. For example, mutational studies
have demonstrated that elimination of the sequence-specific DNA-binding
activity of the yeast homeodomain protein
-2 does not destroy its
ability to bind DNA in concert with a1 (64).
Additionally, c-Myb, in concert with HSF3, stimulates transcription
from the hsp70 promoter through the heat shock element without apparently binding to this sequence (28, 29).
Although the precise function of Cdc5 family members is not understood presently, it is clear that the product of the cdc5+ gene in S. pombe and its homolog in S. cerevisiae are required during G2/M. At present, all available evidence indicates a role for this protein family in DNA binding. However, it is quite possible that Cdc5 family members do not function as transcriptional activators. Indeed, there is precedence for Myb-related proteins which play roles in biological processes other than activation of transcription. For example, human TRF1 and TRF2 and fission yeast taz1p are Myb-related proteins that negatively regulate telomere length (5, 8, 11, 63) and the Myb-related budding yeast protein Reb1p functions in transcriptional termination as well as transcriptional activation of rRNA genes (30). An approach utilizing a combination of genetic, biochemical, and cytological analyses of the isolated Cdc5 family members should lead to an understanding of how Cdc5 facilitates the G2/M transition in eukaryotic cells.
ACKNOWLEDGMENTS
|
|
|---|
We thank members of the laboratories of A. P. Weil and J. Flick for yeast strains and expression plasmids and T. O. Daniel and E. Stein for the human microvascular endothelial cell line library and invaluable technical advice. S. Hiebert kindly provided the plasmid to produce GST-AML. We are grateful to J. Price for flow cytometric analyses. All members of the Gould laboratory, including M. K. Balasubramanian and D. McCollum, are appreciated for valuable discussions and technical advice.
This work was supported by NIH grant GM47728 to K.L.G. and USPHS grants RO1 CA43592 and PO1 CA70404 to J.S.L. and CA71907 to A.T.L. S.M. was supported by USPHS grant NRSA 5T32 CA09302. K.L.G. is an assistant investigator of the Howard Hughes Medical Institute.
FOOTNOTES
* Corresponding author. Mailing address: Department of Cell Biology, Vanderbilt University, School of Medicine, B2309 MCN, 1161 21st Ave. South, Nashville, TN 37232. Phone: (615) 343-9502. Fax: (615) 343-4539. E-mail: ryoma.ohi{at}mcmail.vanderbilt.edu.
REFERENCES
|
|
|---|
| 1. | Althoefer, H., A. Schleiffer, K. Wassmann, A. Nordheim, and G. Ammerer. 1995. Mcm1 is required to coordinate G2-specific transcription in Saccharomyces cerevisiae. Mol. Cell. Biol. 15:5917-5928[Abstract]. |
| 2. | Basi, G., E. Schmid, and K. Maundrell. 1993. TATA box mutations in the Schizosaccharomyces pombe nmt1 promoter affect transcription efficiency but not the transcription start point or thiamine repressibility. Gene 123:131-136[Medline]. |
| 3. |
Baudin, A.,
O. Ozier-Kalogeropoulos,
A. Denouel,
F. Lacroute, and C. Cullin.
1993.
A simple and efficient method for direct gene deletion in Saccharomyces cerevisiae.
Nucleic Acids Res.
21:3329-3330 |
| 4. |
Bernstein, H. S., and S. R. Coughlin.
1997.
Pombe Cdc5-related protein. A putative human transcription factor implicated in mitogen-activated signaling.
J. Biol. Chem.
272:5833-5837 |
| 5. | Bilaud, T., C. Brun, K. Ancelin, C. E. Koering, T. Laroche, and E. Gilson. 1997. Telomeric localization of TRF2, a novel human telobox protein. Nat. Genet. 17:236-239[Medline]. |
| 6. |
Boguski, M. S.,
T. M. Lowe, and C. M. Tolstoshev.
1993.
dbEST database for "expressed sequence tags".
Nat. Genet.
4:332-333[Medline]. (Letter.)
|
| 7. |
Brendeford, E. M.,
A. H. Myrset,
A. B. Hegvold,
M. Lundin, and O. S. Gabrielsen.
1997.
Oncogenic point mutations induce altered conformation, redox sensitivity, and DNA binding in the minimal DNA binding domain of avian myeloblastosis virus v-Myb.
J. Biol. Chem.
272:4436-4443 |
| 8. | Broccoli, D., A. Smogorzewska, L. Chong, and T. de Lange. 1997. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat. Genet. 17:231-235[Medline]. |
| 9. | Christianson, T. W., R. S. Sikorski, M. Dante, J. H. Shero, and P. Hieter. 1992. Multifunctional yeast high-copy-number shuttle vectors. Gene 110:119-122[Medline]. |
| 10. |
Church, G. M., and W. Gilbert.
1984.
Genomic sequencing.
Proc. Natl. Acad. Sci. USA
81:1991-1995 |
| 11. | Cooper, J. P., E. R. Nimmo, R. C. Allshire, and T. R. Cech. 1997. Regulation of telomere length and function by a Myb-domain protein in fission yeast [see comments]. Nature 385:744-747[Medline]. |
| 12. | Creanor, J., and J. M. Mitchison. 1996. The kinetics of the B cyclin p56cdc13 and the phosphatase p80cdc25 during the cell cycle of the fission yeast Schizosaccharomyces pombe. J. Cell Sci. 109:1647-1653[Abstract]. |
| 13. |
Daignan-Fornier, B., and G. R. Fink.
1992.
Coregulation of purine and histidine biosynthesis by the transcriptional activators BAS1 and BAS2.
Proc. Natl. Acad. Sci. USA
89:6746-6750 |
| 14. | Feng, D. F., and R. F. Doolittle. 1990. Progressive alignment and phylogenetic tree construction of protein sequences. Methods Enzymol. 183:375-387[Medline]. |
| 15. |
Frampton, J.,
T. J. Gibson,
S. A. Ness,
G. Doderlein, and T. Graf.
1991.
Proposed structure for the DNA-binding domain of the Myb oncoprotein based on model building and mutational analysis.
Protein Eng.
4:891-901 |
| 16. |
Funk, W. D.,
D. T. Pak,
R. H. Karas,
W. E. Wright, and J. W. Shay.
1992.
A transcriptionally active DNA-binding site for human p53 protein complexes.
Mol. Cell. Biol.
12:2866-2871 |
| 17. |
Gabrielsen, O. S.,
A. Sentenac, and P. Fromageot.
1991.
Specific DNA binding by c-Myb: evidence for a double helix-turn-helix-related motif.
Science
253:1140-1143 |
| 18. |
Goff, S. A.,
K. C. Cone, and V. L. Chandler.
1992.
Functional analysis of the transcriptional activator encoded by the maize B gene: evidence for a direct functional interaction between two classes of regulatory proteins.
Genes Dev.
6:864-875 |
| 19. | Grasser, F. A., K. LaMontagne, L. Whittaker, S. Stohr, and J. S. Lipsick. 1992. A highly conserved cysteine in the v-Myb DNA-binding domain is essential for transformation and transcriptional trans-activation. Oncogene 7:1005-1009[Medline]. |
| 20. |
Guehmann, S.,
G. Vorbrueggen,
F. Kalkbrenner, and K. Moelling.
1992.
Reduction of a conserved Cys is essential for Myb DNA-binding.
Nucleic Acids Res.
20:2279-2286 |
| 21. | Guthrie, C., and G. R. Fink (ed.). 1991. In Guide to yeast genetics and molecular biology, vol. 194. Academic Press, Inc., San Diego, Calif. |
| 22. |
Hegvold, A. B., and O. S. Gabrielsen.
1996.
The importance of the linker connecting the repeats of the c-Myb oncoprotein may be due to a positioning function.
Nucleic Acids Res.
24:3990-3995 |
| 23. |
Hirayama, T., and K. Shinozaki.
1996.
A cdc5+ homolog of a higher plant, Arabidopsis thaliana.
Proc. Natl. Acad. Sci. USA
93:13371-13376 |
| 24. | Introna, M., J. Golay, J. Frampton, T. Nakano, S. A. Ness, and T. Graf. 1990. Mutations in v-myb alter the differentiation of myelomonocytic cells transformed by the oncogene. Cell 63:1289-1297[Medline]. |
| 25. |
Ito, H.,
Y. Fukuda,
K. Murata, and A. Kimura.
1983.
Transformation of intact yeast cells treated with alkali cations.
J. Bacteriol.
153:163-168 |
| 26. |
Juang, Y. L.,
J. Huang,
J. M. Peters,
M. E. McLaughlin,
C. Y. Tai, and D. Pellman.
1997.
APC-mediated proteolysis of Ase1 and the morphogenesis of the mitotic spindle.
Science
275:1311-1314 |
| 27. |
Kanei-Ishii, C.,
A. Sarai,
T. Sawazaki,
H. Nakagoshi,
D. N. He,
K. Ogata,
Y. Nishimura, and S. Ishii.
1990.
The tryptophan cluster: a hypothetical structure of the DNA-binding domain of the myb protooncogene product.
J. Biol. Chem.
265:19990-19995 |
| 28. |
Kanei-Ishii, C.,
J. Tanikawa,
A. Nakai,
R. I. Morimoto, and S. Ishii.
1997.
Activation of heat shock transcription factor 3 by c-Myb in the absence of cellular stress.
Science
277:246-248 |
| 29. |
Kanei-Ishii, C.,
T. Yasukawa,
R. I. Morimoto, and S. Ishii.
1994.
c-Myb-induced trans-activation mediated by heat shock elements without sequence-specific DNA binding of c-Myb.
J. Biol. Chem.
269:15768-15775 |
| 30. | Lang, W. H., B. E. Morrow, Q. Ju, J. R. Warner, and R. H. Reeder. 1994. A model for transcription termination by RNA polymerase I. Cell 79:527-534[Medline]. |
| 31. |
Lew, D. J., and S. I. Reed.
1993.
Morphogenesis in the yeast cell cycle: regulation by Cdc28 and cyclins.
J. Cell Biol.
120:1305-1320 |
| 32. | Lipsick, J. S. 1996. One billion years of Myb. Oncogene 13:223-235[Medline]. |
| 33. | Lundgren, K., S. Allan, S. Urushiyama, T. Tani, Y. Ohshima, D. Frendewey, and D. Beach. 1996. A connection between pre-mRNA splicing and the cell cycle in fission yeast: cdc28+ is allelic with prp8+ and encodes an RNA-dependent ATPase/helicase. Mol. Biol. Cell 7:1083-1094[Abstract]. |
| 34. | Lundgren, K., N. Walworth, R. Booher, M. Dembski, M. Kirschner, and D. Beach. 1991. mik1 and wee1 cooperate in the inhibitory tyrosine phosphorylation of cdc2. Cell 64:1111-1122[Medline]. |
| 35. |
Lydall, D.,
G. Ammerer, and K. Nasmyth.
1991.
A new role for MCM1 in yeast: cell cycle regulation of SW15 transcription.
Genes Dev.
5:2405-2419 |
| 36. | Martin, C., and J. Paz-Ares. 1997. MYB transcription factors in plants. Trends Genet. 13:67-73[Medline]. |
| 37. |
Maundrell, K.
1990.
nmt1 of fission yeast. A highly transcribed gene completely repressed by thiamine.
J. Biol. Chem.
265:10857-10864 |
| 37a. | McCann, S., and J. S. Lipsick. |